February 22, 2025 | Kevin Joseph, LHC Student Assistant
Background
Established to provide health care coverage to low-income people, Medicaid is a state-delivered health insurance program jointly financed by the states and federal government. Medicaid covers over 80 million people nationwide, accounting for approximately a fifth of all healthcare spending nationally. The structure of the Medicaid program allows for state Medicaid agencies to decide (with some parameters) what populations and services are covered (Kaiser Family Foundation, 2024).
For Medicaid enrollees in Alabama Medicaid, the Covered Services Handbook by the Alabama Medicaid Agency does not indicate that colorectal cancer screenings are covered for enrollees (Alabama Medicaid, n.d.). Colorectal cancer is currently the third most diagnosed cancer in the United States, with over 150,000 predicted diagnoses in 2025 (American Cancer Society, 2025). The most recent CDC data shows that 2,510 cases of colorectal cancer were reported in 2021 in Alabama, with a higher age-adjusted rate of 39.4 cases per 100,000 than the national metric of 36 cases per 100,000 people. Additionally, racial disparities in colorectal cancer exist in Alabama, with 43.5 cases of colorectal cancer per 100,000 among Black Alabamians as opposed to 39.4 cases per 100,000 overall (Centers for Disease Control and Prevention, n.d.).
A systematic review of colorectal cancer screening tests, of which there are multiple types, has indicated substantial existing evidence that various colorectal cancer screening types can reduce CRC mortality, with detection benefits generally outweighing procedure risks. Accordingly, the US Preventive Services Task Force concluded with high certainty that screening adults ages 45 to 75 has at least moderate net benefit, with high net benefit for ages 50 to 75 (Lin et al., 2021; US Preventive Services Task Force, 2021). Despite this recommendation, the American Cancer Society notes that state Medicaid Agencies differ in coverage of colorectal cancer screenings for enrollees (American Cancer Society, 2024).
Proposed Legislation
Introduced by Senator Larry Stutts (R-District 6), chair of the Senate Health Committee of the Alabama Legislature, SB27 of the 2025 Regular Session would require the Alabama Medicaid Agency to cover noninvasive colorectal cancer screening tests assigned grade A or B by the US Preventive Services Task Force, as well as any colonoscopy done due to a positive screening result, effective immediately. The covered screenings would include, at a minimum, the guaiac fecal occult blood test (gFOBT), fecal immunochemical test (FIT), and multi-target stool DNA test (sDNA-FIT).
Impact
If SB27 were to pass, Medicaid enrollees in Alabama may receive more colorectal cancer screenings from their providers, leading to earlier, more frequent detection of colorectal cancer. Data from Healthy People 2030 indicates that only 63.5% of people nationally receive colorectal cancer screenings based on recommended guidelines, with worse metrics among non-metropolitan areas and racial/ethnic minorities (Healthy People 2030, n.d.). Considering this current level of screening, along with existing findings on the benefits of colorectal cancer screening and that colorectal cancer is the second leading cancer killer in Alabama according to the Alabama Department of Public Health, coverage of screenings could consequently lead to a reduction in cancer mortality among Alabamians, particularly among Black Alabamians who face a higher prevalence of colorectal cancer (Lin et al., 2021; Alabama Department of Public Health, 2024).
As of February 19th, 2025, there is no fiscal note on SB27, but there would likely be an increased cost for Alabama Medicaid to cover these screenings and associated colonoscopies for positive screenings. However, a systematic review of colorectal cancer screenings indicated that most common colorectal cancer screening strategies, including gFOBT and FIT, are cost-effective and, in the US, even cost-saving compared to no receiving screenings due early detection of colorectal cancers (Ran et al., 2019). Further analysis would needed to understand the implementation costs and health/cost saving benefits in Alabama of enacting SB27.
Next Steps
SB27 is currently pending in Senate Healthcare Committee in the 2025 Regular Session If you want to make your voice heard on this or future legislation, click here to identify your elected officials.
Don’t know what to say? Check out this guide from the American Civil Liberties Union on drafting a letter to your government officials.
References
Alabama Department of Public Health. (2024, September 5). Colorectal Cancer. https://www.alabamapublichealth.gov/colon/
Alabama Medicaid. (n.d.). Covered Services. https://medicaid.alabama.gov/content/4.0_Programs/4.1_Covered_Services.aspx
American Cancer Society. (2024, January 29). Insurance Coverage for Colorectal Cancer Screening. https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/screening-coverage-laws.html
American Cancer Society. (2025, January 16). Key Statistics for Colorectal Cancer. https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html
Centers for Disease Control and Prevention (n.d.). Colorectal Cancer Statistics. https://www.cdc.gov/colorectal-cancer/statistics/index.html
Healthy People 2030. (n.d.). Increase the proportion of adults who get screened for colorectal cancer – C-07. Data. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/cancer/increase-proportion-adults-who-get-screened-colorectal-cancer-c-07/data?group=All%20groups&from=2023&to=2023&state=United%20States&populations=#edit-submit
Kaiser Family Foundation. (2024, May 28). Medicaid 101. https://www.kff.org/health-policy-101-medicaid/?entry=table-of-contents-introduction
Lin J.S., Perdue L.A., Henrikson N.B., Bean S.I., & Blasi P.R. (2021). Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 325(19),1978–1998. https://doi.org/10.1001/jama.2021.4417
Ran, T., Cheng, C., MIsselwitz, B., Brenner, H., Ubels, J., & Schlander, M. (2019). Cost-Effectiveness of Colorectal Cancer Screening Strategies – A Systematic Review. Clinical Gastroenterology and Hepatology, 17(10), 1969-1981. https://doi.org/10.1016/j.cgh.2019.01.014
US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 325(19), 1965-1977. https://doi.org/10.1001/jama.2021.6238